Best gut-health and weight-loss advice from Dr. Chris Thompson on Huberman Lab

Dr. Chris Thompson, a Harvard interventional gastroenterologist at Mass General Brigham, performs weight-loss procedures for a living. On Huberman Lab on September 21, 2026, he still put fiber and lifting ahead of them.¹ His most memorable line came from a mouse study in which fiber-starved gut microbes thinned the colonic mucus layer five to six times over.² Some of his advice holds up in human trials. Some of it rests on mice or clinic habit, and that difference should decide what you change first.

Huberman Lab episode

01What fiber-starved microbes do to the mucus layer

The episode discusses fiber and the gut barrier.¹ The direct evidence comes from Desai, Seekatz, Koropatkin, and colleagues, who published the experiment in Cell in 2016. Germ-free mice colonized with a synthetic human gut community lost mucus on a fiber-free diet until the inner layer was five to six times thinner, and the pathogen Citrobacter rodentium gained a foothold.²

The mucus erosion itself was measured in mice. The closest human signal is indirect. Miele's 2009 study found higher intestinal permeability and damaged tight junctions in people with fatty liver disease, which shows the gut barrier and metabolic health are linked in humans.¹¹ That study did not test fiber, so it cannot show that low fiber caused the leak. Treat the mouse result as a plausible mechanism and eat fiber for the reasons that have human outcome data.

Those reasons are strong. Reynolds, Mann, Cummings, and colleagues pooled 185 prospective studies and 58 clinical trials for their 2019 Lancet review. People with the highest fiber intakes had 15 to 30% lower all-cause and cardiovascular mortality than people with the lowest. The broadest spread of benefits showed up at 25 to 29 grams a day, and the dose-response data suggested more fiber could protect further.⁴ Huberman cited 35 grams a day for men. The IOM Adequate Intake is 38 grams for men under 50 and 25 grams for women under 50, which works out to about 14 grams per 1,000 kcal.³ The podcast number is close enough. Build toward the IOM number for your age and sex with the fiber targets for active adults.

Resistant starch is one of the better-tested ways to feed colonic bacteria. Ni and colleagues randomized 200 adults with NAFLD to 40 grams a day of high-amylose maize resistant starch or a control starch for four months. Intrahepatic triglyceride fell 9.08 percentage points more than on the control starch, and still 5.89 points more after adjusting for weight loss.¹² Johnston gave 20 adults with metabolic syndrome 40 grams a day of RS2 at a stable weight and measured a 19% rise in insulin sensitivity.¹³ Both trials used purified starch at doses far above what an ordinary diet supplies. Cooked and cooled potatoes, green bananas, oats, and beans give you smaller amounts of the same fiber class, and they are where a gut microbiome plan should start.

02Why fermented foods and fiber do different jobs

Wastyk, Sonnenburg, and colleagues studied 36 healthy adults for 10 weeks. Thirty-four were randomized, while two were assigned to the high-fiber arm at their request. The fermented-food arm gained microbiome diversity and lowered 19 circulating inflammatory proteins, including interleukin-6, on secondary profiling. The primary cytokine-response score was unchanged, and the high-fiber arm did not gain diversity in that window.⁵ That surprises anyone who assumed fiber was the whole gut-health story. Fiber still owns the mortality and cholesterol data. In this trial, fermented foods moved diversity and inflammatory-protein profiles while fiber did not.

Participants in the fermented arm worked up to about six servings a day of foods like yogurt, kefir, kombucha, kimchi, and fermented vegetables.⁵ That is a study protocol. One or two servings a day is a sensible place to start, and nobody should assume the smaller dose buys the same diversity gain. If live cultures are the goal, choose products labeled as containing live cultures and follow their storage instructions.

Skip the butyrate capsule. Uncoated oral butyrate is absorbed high in the gut, which is why Roda's group had to design a coated formulation to get it as far as the ileum and colon.¹⁴ Fermentable fiber puts butyrate where colon cells use it, because the bacteria make it there. Eat both fiber and fermented foods, and expect different things from each.

03What a normal bowel rhythm looks like on a high-protein diet

Thompson gave a rough rule of thumb on the podcast for how often to go and how long a gap should worry you. That is one clinician's heuristic from practice. Gastroenterologists use symptom-based Rome V criteria to evaluate functional constipation, including stool form, straining, the feeling of incomplete emptying, and frequency.²³ A daily bowel movement that takes effort and comes out hard still counts as a problem.

On a high-protein cut, look first at what left the plate to make room for protein. Beans, oats, fruit, and water are the usual casualties. Put those back before you lower the protein target. The full fix is in constipation on a high-protein diet.

04How gut hormones pace a meal from stomach to colon

Appetite runs on a relay. Ghrelin rises when the stomach is empty. Nutrients reaching the small intestine stimulate CCK, GLP-1, and PYY, which contribute to satiety and delayed gastric emptying.²⁴

Hall's inpatient trial offers a human glimpse of that relay responding to food. On the unprocessed menu, PYY rose and ghrelin fell compared with baseline.⁸ The trial cannot say which feature of the food caused the shift. It does show that the native signals respond to what is on the plate.

A long-acting GLP-1 injection sustains receptor activation beyond the short post-meal signal.²⁴ Food still runs the rest of the relay, and the native relay is all you have left if the drug stops. Build meals around protein, fiber, and minimally processed food while you are on the medication, because those are the signals you will rely on after it.

05How an ultra-processed menu added 500 calories a day

Hall, Ayuketah, and colleagues housed 20 adults at the NIH Clinical Center and gave them ultra-processed and unprocessed menus for two weeks each. The menus offered matched calories, sugar, sodium, fiber, and macronutrients, and people ate as much as they wanted. On the ultra-processed foods menu they ate 508 ± 106 kcal a day more, ate faster, and gained 0.9 kg. On the unprocessed menu they lost 0.9 kg.⁸ Nobody decided to overeat. The trial was too small and too short to say whether eating speed, texture, or energy density did the work.

Dicken's 2025 crossover asked whether processing still matters when both diets look healthy on paper. Fifty-five adults ate two 8-week diets that both followed UK Eatwell Guide targets, one minimally processed and one ultra-processed. Fifty participants comprised the intention-to-treat analysis, in which weight fell 2.06% on the minimally processed diet and 1.05% on the ultra-processed diet.¹⁷ Both diets produced weight loss. The minimally processed version produced about twice as much.

Fructose from a soda is a different load than fructose in fruit. Jang's mouse work found the small intestine clears about 90% of a moderate fructose dose. Larger doses spill past it to the liver and the colonic microbes.¹⁸ The human threshold has not been mapped the same way. The practical move is still simple. Keep the fruit and cut the sugary drinks, since a soda delivers a large dose of fructose in minutes.

06How many people stop GLP-1 drugs within a year

Rodriguez and colleagues followed 125,474 U.S. adults with overweight or obesity who started liraglutide, semaglutide, or tirzepatide. Within a year, 53.6% had discontinued. The figure was 46.5% among people with type 2 diabetes and 64.8% among people without it.⁷ The cohort defines discontinuation as a medication gap of at least 60 days. It cannot tell you whether patients intended long-term treatment or whether cost, side effects, or reaching a goal weight drove the decision. For scale, Gallup's 2026 poll put current GLP-1 use for weight loss at 11% of U.S. adults and lifetime use at 15%.⁶ Those are prevalence estimates, and they do not measure discontinuation.

Staying on the drug has a cardiovascular case. SELECT randomized 17,604 adults with overweight or obesity and established heart disease, none with diabetes, to weekly semaglutide 2.4 mg or placebo. Semaglutide cut major adverse cardiovascular events with a hazard ratio of 0.80.¹⁵ Weight usually comes back after stopping. The food-noise evidence after stopping GLP-1s is thinner, because withdrawal trials measured regain and never re-ran the craving scales. GLP-1 microdosing for maintenance is clinic practice with no labeled schedule, so any taper belongs in a conversation with your prescriber.

Before you start, decide whether you can afford and tolerate the drug for years, and what your food and training will look like if you stop. Newer drugs do not change that question. Jastreboff's 2023 phase 2 trial of retatrutide, a triple agonist, reported 24.2% mean weight loss at the 12 mg dose after 48 weeks in 338 adults.¹⁶ As of September 2026, retatrutide remains investigational and unapproved, although Lilly has reported Phase 3 topline results.²⁵ The idea that its glucagon component spares muscle is a hypothesis, and that phase 2 trial did not test it. Whatever the drug, use how to preserve muscle on GLP-1 medications for the protein and lifting work no drug does for you.

07Why a normal BMI and A1C can hide early insulin resistance

Araújo, Cai, and Stevens applied a strict definition of metabolic health to NHANES 2009 to 2016, using waist size, blood pressure, fasting glucose and A1C, triglycerides, and HDL cholesterol. Only 12.2% of U.S. adults met every target. Fewer than one in three normal-weight adults did.¹⁹ A healthy BMI rules out very little.

Tabák, Jokela, Akbaraly, and colleagues followed British civil servants in the Whitehall II cohort before some of them developed diabetes. Glucose and insulin sensitivity changed sharply in the three to six years before diagnosis.²⁰ That window is early enough to change the plate. A1C reflects roughly two to three months of average glucose, so it can move later than daily glucose patterns.²⁶ Routine fasting-insulin testing is not recommended for most people at risk, so discuss guideline-supported screening with a clinician.²⁶ CGM can show short-term glucose patterns, but evidence is insufficient to use it for screening or diagnosis of prediabetes or diabetes.²⁶

08Why lifting comes before the calorie deficit

Thompson performs procedures for a living and still put the barbell in front of the endoscope. The body-composition data explains why. In the STEP 1 DXA substudy, about 39% of total weight lost on semaglutide was DXA-measured lean body mass.⁹ That measurement includes nonmuscle lean tissue, so it does not quantify muscle loss. Plan protein and resistance training before the deficit, while appetite is still normal and training still feels good.

Fothergill's 14 Biggest Loser contestants still burned about 500 kcal a day less at rest than predicted six years after the show.¹⁰ That is the extreme end. Most adult weight-loss studies find adaptive thermogenesis closer to 50 to 300 kcal a day, as the metabolic damage from dieting review lays out. Part of the drop is efficiency. After a 10% weight loss, Rosenbaum measured skeletal muscle work efficiency at low loads about 25% higher, so the same walk burns less.²¹ Crash deficits like the show's are how people end up near the outlier.

Surgery has one effect diet does not copy well. Rubino's 2006 rat work on duodenal-jejunal exclusion improved glucose control without a difference in weight, which points to signaling from the upper small intestine.²² If you go that route, the nutrition follow-through is in bariatric surgery nutrition.

Most people who heard this episode will never need a bypass or an injection. The ones who do will still need fiber on the plate and a barbell on the floor. Build that routine first, so the drug or the procedure has something to stand on and you have something to fall back on if you ever stop.